Search

everythinglearnresearchcommunity

for

Search:↓

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Some alternative therapies for vitiligo show promise but need more research.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

People with alopecia areata have higher insulin resistance.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Vitamin D might help treat some types of hair loss, but more research is needed.

New treatments focusing on immune pathways show promise for stubborn hair loss.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Skin problems are common in people with diabetes and controlling blood sugar can reduce these issues.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.